We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other most expensive stocks insiders are dumping in March.
After being in the green for a few trading sessions, the broader market index slid 0.8% on Wednesday, and blue-chip companies declined 0.1%. The NASDAQ Composite was down 1.6% in the early afternoon. On Tuesday, Trump provided an update on tariffs, saying they will likely be more “lenient than reciprocal,” suggesting a more relaxed approach, reports CNBC.
As investors process daily market developments, uncertainty continues to impact the market. In these periods, insider trading often attracts attention, as purchases of company stock by executives may suggest confidence in the company’s future. However, insider selling doesn’t necessarily imply a lack of faith—it may be driven by personal financial needs or a desire for diversification. Executives frequently rely on pre-established plans, such as 10b5-1, to maintain transparency. While insider trading can provide useful insights, it should be evaluated in the context of a company’s financial health, market trends, and industry changes.
What are some of the most expensive stocks insiders have been selling this month so far? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where at least three insiders had sold shares in March. From there, we ranked the 20 stocks with the highest average price per share in times of sales.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
With each stock, we note the average price per share of these sales and the stock’s market capitalization.
An engineer at a workbench surrounded by automotive parts, tools, and microchips.
Thermo Fisher Scientific Inc. (NYSE:TMO)
Market Capitalization: $194.04 billion
Thermo Fisher Scientific Inc. (NYSE:TMO) provides a wide range of life sciences solutions, analytical instruments, diagnostics, laboratory products, and biopharma services globally. Its offerings include products for biological research, drug and vaccine production, clinical diagnostics, and laboratory research across various industries. The Waltham, Massachusetts-headquartered company operates under several brands such as Thermo Scientific, Invitrogen, and Applied Biosystems.
For the full year 2024, Thermo Fisher (NYSE:TMO) disclosed revenue of $42.88 billion, flat compared to 2023. Full year GAAP diluted earnings per share (EPS) grew 7% to $16.53.
In recent developments, Thermo Fisher (NYSE:TMO) launched the Thermo Scientific Vulcan Automated Lab, a system designed to improve productivity and yield, and reduce costs for semiconductor manufacturers. The solution aims to address the growing demand for advanced metrology data in semiconductor manufacturing as technologies become more complex. Marc N. Casper, CEO of Thermo Fisher, emphasized the company’s expertise in electron microscopy and AI to help semiconductor manufacturers enhance efficiency.
In March, three insiders, including the chairman and CEO, sold around $12.28 million worth of Thermo Fisher shares at an average price of $520.17 per share. The stock currently trades at $514.34 per share, having lost 1.13% year-to-date, and 9.58% over the past 12 months.
Based on 18 Wall Street analysts’ ratings, Thermo Fisher (NYSE:TMO) stock is a “Strong Buy” with a price target of $662.00. According to TipRanks, the average price target represents a 28.71% upside from the latest price.
Thermo Fisher (NYSE:TMO) is also one of the 12 best diagnostics stocks to invest in right now.
Overall, TMO ranks 8th on our list of most expensive stocks insiders are dumping in March. While we acknowledge the potential of TMO our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TMO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
